127 related articles for article (PubMed ID: 6745468)
1. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
Shimizu Y
Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468
[TBL] [Abstract][Full Text] [Related]
2. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061
[TBL] [Abstract][Full Text] [Related]
3. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
4. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
Witzgall H; von Werder K; Weber PC
J Steroid Biochem; 1983 Nov; 19(5):1671-6. PubMed ID: 6645503
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
[TBL] [Abstract][Full Text] [Related]
7. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
Witzgall H; Thayil G; Weber PC
Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
[TBL] [Abstract][Full Text] [Related]
8. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
Ojima M; Itoh N; Kusano Y; Yaginuma K; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):197-207. PubMed ID: 3709883
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid response to low dose adrenocorticotropin infusion.
Tuck ML; Sowers JR; Asp ND; Viosca SP; Berg G; Mayes DM
J Clin Endocrinol Metab; 1981 Mar; 52(3):440-6. PubMed ID: 6257748
[TBL] [Abstract][Full Text] [Related]
11. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
Ojima M; Aida M; Kambegawa A
Tohoku J Exp Med; 1978 Apr; 124(4):367-79. PubMed ID: 663934
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
[TBL] [Abstract][Full Text] [Related]
14. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Guthrie GP
J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
[TBL] [Abstract][Full Text] [Related]
15. Paper chromatographic systems for the separation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone.
Witzgall H; Hassan-Ali S
J Chromatogr; 1980 Sep; 198(1):70-5. PubMed ID: 7430313
[TBL] [Abstract][Full Text] [Related]
16. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
17. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
[TBL] [Abstract][Full Text] [Related]
18. Effects of potassium loading in normal man on dopaminergic control of mineralocorticoids and renin release.
Witzgall H; Behr J
J Hypertens; 1986 Apr; 4(2):201-5. PubMed ID: 3519763
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone simultaneously measured in normal subjects and adrenocortical disorders.
Ojima M; Kambegawa A
Tohoku J Exp Med; 1980 Sep; 132(1):75-85. PubMed ID: 7209971
[TBL] [Abstract][Full Text] [Related]
20. 17 alpha-hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family.
D'Armiento M; Reda G; Kater C; Shackleton CH; Biglieri EG
J Clin Endocrinol Metab; 1983 Apr; 56(4):697-701. PubMed ID: 6300162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
